Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ZimVie Inc. ZIMV
$10.38
+$0.15 (1.47%)
На 18:05, 12 мая 2023
-13.29%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
268654255.00000000
-
week52high
25.25
-
week52low
5.05
-
Revenue
913862000
-
P/E TTM
-11
-
Beta
0.00000000
-
EPS
-2.48000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 20:30
Описание компании
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| JP Morgan | Neutral | 17 июн 2022 г. | |
| Guggenheim | Neutral | 18 мар 2022 г. | |
| Credit Suisse | Underperform | 01 мар 2022 г. | |
| Barclays | Underweight | 21 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. | D | 0 | 5131946 | 01 февр 2023 г. |
| ASAR VINIT K | A | 6790 | 2188 | 31 дек 2022 г. |
| CRAWFORD SALLY | A | 3252 | 957 | 31 дек 2022 г. |
| KING DAVID P | A | 12687 | 4240 | 31 дек 2022 г. |
| Kuntz Richard | A | 3252 | 957 | 31 дек 2022 г. |
| Matusinec Karen | A | 3252 | 957 | 31 дек 2022 г. |
| Harmon David John | D | 1630 | 107 | 01 окт 2022 г. |
| Heppenstall Richard | D | 26308 | 1058 | 01 окт 2022 г. |
| ASAR VINIT K | A | 4602 | 1990 | 30 сент 2022 г. |
| CRAWFORD SALLY | A | 2295 | 871 | 30 сент 2022 г. |
Новостная лента
ZimVie to Present at the 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
28 дек 2022 г. в 09:00
WESTMINSTER, Colo., Dec. 28, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California.
ZimVie Inc. (ZIMV) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 17:03
ZimVie Inc. (NASDAQ:ZIMV ) Q3 2022 Results Conference Call November 9, 2022 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group IR Vafa Jamali - President and CEO Rich Heppenstall - CFO Conference Call Participants Operator Good afternoon, and welcome to ZimVie's Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
ZimVie to Report Third Quarter 2022 Financial Results on November 9, 2022
GlobeNewsWire
19 окт 2022 г. в 16:10
WESTMINSTER, Colo., Oct. 19, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the third quarter 2022 after market close on Wednesday, November 9, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
ZimVie to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
GlobeNewsWire
29 авг 2022 г. в 16:10
WESTMINSTER, Colo., Aug. 29, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will participate in Morgan Stanley's 20th Annual Global Healthcare Conference held in New York, New York.
ZimVie: Disappointing Guidance Prompts Caution
Seeking Alpha
25 авг 2022 г. в 18:08
ZimVie was spun out of Zimmer Biomet in early March. The company recently reported disappointing Q2 results with weak revenues and poor guidance.